Pill Bottle Press About Pill Bottle Press focuses on extremely raw, completely unfiltered works centered around mental and physical illness as well as the kind of emotions that may not be appropriate to show to others. Are you pissed off that you have chronic pain? Hate your depression and hate having to overcompensate for it in your daily life? Hate the irony of remembering to take your ADHD meds every. single. fucking. day? Pill Bottle Press is for you, then.So, go ahead and scream. Country of Publication & Year Established United States Established in 2026 Publication Medium & Frequency Electronic Publication Electronic PublicationUnknown publication frequency AI Policy Human-created work only; no AI use allowed Statistics Synopsis FasterPill Bottle Press's overall average response time is faster than most magazines. Collapse section Fiction Temp Closed Audience:Open to a broad Audience, including: People living with mental health conditions, People with disabilities, Specific group.Genres: GeneralLengths: Flash Fiction: Up to 1,000 words; Up to 2 pieces. Short Story: 1,000 - 1,500 words; Up to 2 pieces. Short Story: 1,501 - 4,000 words.Styles:Open to all/most Styles, including: Literary.Topics: Health/Medicine: Illness, Mental health.Payment:Token payment (under 1 US cent per word) Token payment. Details: USD $1.Submissions:Method: Email. Reprints: Reprints are NOT allowed.Simultaneous submissions: Simultaneous submissions are allowed.Media: Text. Collapse section Nonfiction Temp Closed Audience:Open to a broad Audience, including: People living with mental health conditions, People with disabilities, Specific group.Lengths: Essay: Up to 1,500 words; Up to 2 pieces. Essay: 1,501 - 4,000 words. Narrative Nonfiction: Up to 1,500 words; Up to 2 pieces. Narrative Nonfiction: 1,501 - 4,000 words.Styles:Open to all/most Styles, including: Literary.Topics: Health/Medicine: Illness, Mental health.Payment:Token payment (under 1 US cent per word) Token payment. Details: USD $1.Submissions:Method: Email. Reprints: Reprints are NOT allowed.Simultaneous submissions: Simultaneous submissions are allowed.Media: Text. Collapse section Poetry Temp Closed Audience:Open to a broad Audience, including: People living with mental health conditions, People with disabilities, Specific group.Genres: GeneralLengths: Poem: No line limits known; Up to 4 pieces.Poetry Forms:Open to all/most Forms.Styles:Open to all/most Styles, including: Literary.Topics: Health/Medicine: Illness, Mental health.Payment:Token payment (under US$5 per poem) Token payment. Details: USD $1.Submissions:Method: Email. Reprints: Reprints are NOT allowed.Simultaneous submissions: Simultaneous submissions are allowed.Media: Text. Collapse section Visual Art Temp Closed Audience:Open to a broad Audience, including: People living with mental health conditions, People with disabilities, Specific group.Lengths: Artwork: Up to 5 pieces.Art Media: Open to all/most Art Media.Art Styles:Open to all/most Art Styles.Topics: Health/Medicine: Illness, Mental health.Payment:Token payment (under US$10 per piece) Token payment. Details: USD $1.Submissions:Method: Email. Reprints: Reprints are NOT allowed.Simultaneous submissions: Simultaneous submissions are allowed.Media: Image. Always check guidelines for details and restrictions. If you aren't familiar with these terms, see our glossary. Go to publication's website Report: Submission/Response Correction/Update New Cover ArtSocial:Bluesky @pillbottlepress.bsky.socialInstagram @pillbottlepressX (Twitter) @pillbottlepress Support this Publisher: Support on Ko-fi For the Editor(s): Request Interview Duosuma Submission Manager Link to Duotrope Pill Bottle Press Submission Statistics The statistics in this section are compiled from submission reports sent to us through our submission tracker. They are not provided by the publication's editors/staff or by Duotrope's admins. Information in this section is updated a few times per day. Learn more about the statistics. Filter: Category: All Categories Fiction Nonfiction Poetry Visual Art Group by submission Include outliers Accuracy We have received 7 reports from 7 different members within the past 12 months. The more responses reported, the more accurate the information. Days Reported 2 min | 29.4 mean avg | 32.0 median | 76 max days (25.7 std dev) Other Information The editors will try to make a decision within 60 days. (14.3 % of the responses reported to us for this listing have taken longer than 60 days.) Do not query on the status of your submission before 60 days have passed. Most recent response reported was received on 13 Apr 2026. Responses have been received for submissions sent as recently as 26 Feb 2026. Date compiled: 15 Sep 2026 10:09 UTC (less than a minute ago). Work submitted here was also submitted to...This section is available to subscribers only. Sign up and start your free trial today!Members accepted here also had work accepted by...This section is available to subscribers only. Become a member and start your free trial today! Your Submissions This section is available to subscribers only. Join today! Before SubmittingWe cannot guarantee that the information on this page is correct. It is not unusual for publications to evolve or close without notice. We do our best to keep up, but it isn't always possible. Duotrope listings do not imply endorsement or recommendation of the project being listed. Before submitting, you should use your own judgment to determine whether the project meets your standards.Always read the full guidelines provided by the publisher.Try to read at least one previous publication to get a better idea of what the editor would like to see.Unless the publisher's guidelines state otherwise, always use industry standard manuscript formatting.Be professional, patient, and persistent. DatesLast Updated: 11 Jul 2026We check their guidelines for changes every four weeks, and we audit the listing twice a year. Cookie Consent: This site uses secure first-party cookies for essential, preference-setting, and statistical purposes. We do not use any marketing, advertising, or third-party cookies. Read our full cookie policy. Accept All Cookies Allow Essential Cookies Only